- Home
- CDXS vs ZVRA Comparison
CDXS vs ZVRA Comparison
Compare CDXS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- ZVRA
- Stock Information
- Founded
- CDXS 2002
- ZVRA 2006
- Country
- CDXS United States
- ZVRA United States
- Employees
- CDXS N/A
- ZVRA N/A
- Industry
- CDXS Major Chemicals
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CDXS Industrials
- ZVRA Health Care
- Exchange
- CDXS Nasdaq
- ZVRA Nasdaq
- Market Cap
- CDXS 361.3M
- ZVRA 419.5M
- IPO Year
- CDXS 2010
- ZVRA 2015
- Fundamental
- Price
- CDXS $4.18
- ZVRA $7.69
- Analyst Decision
- CDXS Buy
- ZVRA Strong Buy
- Analyst Count
- CDXS 2
- ZVRA 7
- Target Price
- CDXS $11.00
- ZVRA $21.20
- AVG Volume (30 Days)
- CDXS 566.1K
- ZVRA 380.4K
- Earning Date
- CDXS 02-27-2025
- ZVRA 03-27-2025
- Dividend Yield
- CDXS N/A
- ZVRA N/A
- EPS Growth
- CDXS N/A
- ZVRA N/A
- EPS
- CDXS N/A
- ZVRA N/A
- Revenue
- CDXS $64,446,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- CDXS N/A
- ZVRA N/A
- Revenue Next Year
- CDXS $2.02
- ZVRA $330.04
- P/E Ratio
- CDXS N/A
- ZVRA N/A
- Revenue Growth
- CDXS N/A
- ZVRA 47.85
- 52 Week Low
- CDXS $2.56
- ZVRA $4.20
- 52 Week High
- CDXS $6.08
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- CDXS 41.30
- ZVRA 48.77
- Support Level
- CDXS $4.14
- ZVRA $7.64
- Resistance Level
- CDXS $4.41
- ZVRA $8.21
- Average True Range (ATR)
- CDXS 0.22
- ZVRA 0.29
- MACD
- CDXS 0.01
- ZVRA 0.03
- Stochastic Oscillator
- CDXS 38.89
- ZVRA 57.93
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.